Critical Care Diagnostics Market Size, Share & Growth [2031]
Critical Care Diagnostics Market Size, Share & Growth [2031]
Segments - Critical Care Diagnostics Market by Test Type (Routine & Special Chemistry, Flow Cytometry, Immunoproteins, Microbial & Infectious Diseases, and Others), Application (Operation Rooms, Emergency Rooms, and Intensive Care Units), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-1008
| 4.7 Rating
| 81 Reviews
| 159 Pages
| Format :
Report Description
The global critical care diagnostics market size was USD 1.1 Bn in 2022 and is likely to reach USD 1.8 Bn by 2031, expanding at a CAGR of 5.6% during 2023–2031. The market growth is attributed to the increasing technological advancement and rising prevalence of infectious diseases and chronic disorders.
Critical care refers to the fulfillment of the requirement of patients who need immediate medical attention due to life-threatening health conditions. In such conditions, patients are usually facing the rapid deterioration of vital organs or are at risk of serious consequences.
Critical care diagnostics tests are extensively performed for intensive care and diagnosis of life-threatening diseases of patients. These tests are widely adopted due to certain advantages such as easy-to-use, rapid, and cost-effective with accurate results. Across the globe, critical care diagnostics are used in the operating room, emergency room, and intensive care units (ICUs).
Rising cases of serious illness, which require admission to the emergency room or urgent medical services present major driving factors for market expansion. As per global health data, around 20% of those who are admitted to hospitals are rushed to emergency rooms.
The rapid growth of various types of technological advancement is another major factor boosting the market. For instance, Abbott combines the i-Stat blood gas analyzer, and self-contained cartridges, with electrochemical detection and microfluidic components to give accurate and sensitive results.
The market report finds that the COVID-19 pandemic has negatively impacted the growth of the market. The implementation of lockdowns and transport bans has affected the production of medical equipment.
Critical Care Diagnostics Market Dynamics
The global critical care diagnostics market report has up-to-date insights that help in formulating a strategic roadmap about the estimated market scenario and performance during 2023 to 2031.
Drivers
Increasing awareness for early diagnosis and treatment among people and rapid development of accurate and cost-effective diagnostic tests are expected to boost the market growth. Wide adoption of data management and connectivity through inter-operability to electronic health records (EHR) is anticipated to push the market expansion. However, the increasing adoption of remote communications and the availability of advanced telehealth services are projected to drive the market growth in the coming years.
Restraints
The lack of skilled professionals for critical care diagnostics and the high cost of tests act as major challenges that can hamper the market expansion during the forecast period.
Opportunities
Ongoing extensive R&D activities to help develop several innovative diagnostic kits are anticipated to create lucrative opportunities for the market players.
Scope of Critical Care Diagnostics Market Report
The global critical care diagnostics market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Critical Care Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2020–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Test Type (Routine & Special Chemistry, Flow Cytometry, Immunoproteins, Microbial & Infectious Diseases, and Others), and Application (Operation Rooms, Emergency Rooms, and Intensive Care Units) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott.; Beckman Coulter, Inc.; BD.; Bayer AG; F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Chembio Diagnostics, Inc.; Nanōmix, Inc.; and Sysmex |
Critical Care Diagnostics Market Segment Insights
Based on test type, the critical care diagnostics market is segmented into routine & special chemistry, flow cytometry, immunoproteins, microbial & infectious diseases, and others. The immunoproteins segment is expected to represent a key share of the market during the forecast period owing to increasing rapid and accurate diagnosis and also a reduction in the recovery time of patients.
Growing awareness about better healthcare among patients and increasing knowledge of physicians for target therapy are factors responsible for segment growth. Additionally, immunoprotein diagnostic tests are widely used for several applications to detect numerous health conditions that are related to a weakening immune system.
On the basis of application, the market is divided into operation rooms, emergency rooms, and intensive care units (ICUs). The emergency rooms segment is expected to expand at a rapid pace during the forecast period owing to the rising incidence of patients admitted for emergency services. Increasing use of advanced diagnostic tools in hospitals and continuous upgrades of emergency rooms to meet the needs of patients having immediate medical attention are likely to propel the segment growth.
In terms of region, the global critical care diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the global market and is estimated to hold a large market share in the coming years. Key factors that fuel the regional market growth are the presence of major global players, the rising number of geriatric populations, and the early adoption of advanced technology of critical care diagnostic devices.
Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to improved healthcare infrastructure and a growing number of specialized hospitals for intensive care, especially in major economies such as India and China. Additionally, rising improvement of the primary healthcare systems and extended insurance coverage of patients are the new health reforms that boost the regional market growth.
Segments
The global critical care diagnostics market has been segmented on the basis of
Test Type
- Routine & Special Chemistry
- Flow Cytometry
- Immunoproteins
- Microbial & Infectious Diseases
- Others
Application
- Operation Rooms
- Emergency Rooms
- Intensive Care Uniits
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Key players competing in the global critical care diagnostics market are Abbott.; Beckman Coulter, Inc.; BD.; Bayer AG; F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Chembio Diagnostics, Inc.; Nanōmix, Inc.; and Sysmex
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide.
- In August 2020, Philips introduced a Rapid Equipment Deployment Kit for ICU ramp-ups. This kit provides hospitals with a way to quickly and easily expand their critical care capacity.
Frequently Asked Questions
The global critical care diagnostics market size was valued at around USD 1.1 billion in 2022 and is likely to reach USD 1.8 billion by 2031.
The global critical care diagnostics market is estimated to register a compound annual growth rate (CAGR) of around 5.6% during the forecast period.
For region analysis, North America dominates the global critical care diagnostics market during the forecast period.
Some of the key global critical care diagnostics market players are Abbott.; Beckman Coulter, Inc.; BD.; Bayer AG; F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Chembio Diagnostics, Inc.; Nanōmix, Inc.; and Sysmex
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Critical Care Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Critical Care Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Critical Care Diagnostics Market - Supply Chain
4.5. Global Critical Care Diagnostics Market Forecast
4.5.1. Critical Care Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Critical Care Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Critical Care Diagnostics Market Absolute $ Opportunity
5. Global Critical Care Diagnostics Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Critical Care Diagnostics Market Size and Volume Forecast by Applications
5.3.1. Operation Rooms
5.3.2. Emergency Rooms
5.3.3. Intensive Care Uniits
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Critical Care Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Critical Care Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Critical Care Diagnostics Demand Share Forecast, 2019-2026
7. North America Critical Care Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Critical Care Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Critical Care Diagnostics Market Size and Volume Forecast by Applications
7.4.1. Operation Rooms
7.4.2. Emergency Rooms
7.4.3. Intensive Care Uniits
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Critical Care Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Critical Care Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Critical Care Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Critical Care Diagnostics Market Size and Volume Forecast by Applications
8.4.1. Operation Rooms
8.4.2. Emergency Rooms
8.4.3. Intensive Care Uniits
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Critical Care Diagnostics Demand Share Forecast, 2019-2026
9. Europe Critical Care Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Critical Care Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Critical Care Diagnostics Market Size and Volume Forecast by Applications
9.4.1. Operation Rooms
9.4.2. Emergency Rooms
9.4.3. Intensive Care Uniits
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Critical Care Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Critical Care Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Critical Care Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Critical Care Diagnostics Market Size and Volume Forecast by Applications
10.4.1. Operation Rooms
10.4.2. Emergency Rooms
10.4.3. Intensive Care Uniits
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Critical Care Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Critical Care Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Critical Care Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Critical Care Diagnostics Market Size and Volume Forecast by Applications
11.4.1. Operation Rooms
11.4.2. Emergency Rooms
11.4.3. Intensive Care Uniits
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Critical Care Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Critical Care Diagnostics Market: Market Share Analysis
12.2. Critical Care Diagnostics Distributors and Customers
12.3. Critical Care Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott.
12.4.2. Beckman Coulter, Inc.
12.4.3. BD.
12.4.4. Bayer AG
12.4.5. F. Hoffmann-La Roche Ltd
12.4.6. Siemens Healthcare GmbH
12.4.7. Bio-Rad Laboratories, Inc.
12.4.8. Chembio Diagnostics, Inc.
12.4.9. Nanōmix, Inc.
12.4.10. Sysmex
Methodology
Related Reports
Some other reports from this category!
Our Clients
